These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of nicotine on response inhibition and interference control. Ettinger U; Faiola E; Kasparbauer AM; Petrovsky N; Chan RC; Liepelt R; Kumari V Psychopharmacology (Berl); 2017 Apr; 234(7):1093-1111. PubMed ID: 28150023 [TBL] [Abstract][Full Text] [Related]
6. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder. Potter AS; Newhouse PA Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679 [TBL] [Abstract][Full Text] [Related]
7. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia. D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030 [TBL] [Abstract][Full Text] [Related]
8. Effect of nicotine on saccadic eye movement latencies in non-smokers. Bowling AC; Donnelly JF Hum Psychopharmacol; 2010 Jul; 25(5):410-8. PubMed ID: 20589920 [TBL] [Abstract][Full Text] [Related]
9. The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine. Rycroft N; Hutton SB; Rusted JM Psychopharmacology (Berl); 2006 Nov; 188(4):521-9. PubMed ID: 16896958 [TBL] [Abstract][Full Text] [Related]
10. Individual differences in working memory moderate the relationship between prosaccade latency and antisaccade error rate. Schaeffer DJ; Chi L; Krafft CE; Li Q; Schwarz NF; McDowell JE Psychophysiology; 2015 Apr; 52(4):605-8. PubMed ID: 25382828 [TBL] [Abstract][Full Text] [Related]
12. Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Schmechtig A; Lees J; Grayson L; Craig KJ; Dadhiwala R; Dawson GR; Deakin JF; Dourish CT; Koychev I; McMullen K; Migo EM; Perry C; Wilkinson L; Morris R; Williams SC; Ettinger U Psychopharmacology (Berl); 2013 May; 227(2):331-45. PubMed ID: 23430159 [TBL] [Abstract][Full Text] [Related]
13. A double-blind placebo-controlled experimental study of nicotine: II--Effects on response inhibition and executive functioning. Dawkins L; Powell JH; West R; Powell J; Pickering A Psychopharmacology (Berl); 2007 Mar; 190(4):457-67. PubMed ID: 17205318 [TBL] [Abstract][Full Text] [Related]
14. Evidence for positive allosteric modulation of cognitive-enhancing effects of nicotine in healthy human subjects. Hahn B; Shrieves ME; Olmstead CK; Yuille MB; Chiappelli JJ; Pereira EFR; Albuquerque EX; Fawcett WP Psychopharmacology (Berl); 2020 Jan; 237(1):219-230. PubMed ID: 31686175 [TBL] [Abstract][Full Text] [Related]
15. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Poltavski DV; Petros T Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655 [TBL] [Abstract][Full Text] [Related]
17. Effects of procyclidine on eye movements in schizophrenia. Ettinger U; Kumari V; Zachariah E; Galea A; Crawford TJ; Corr PJ; Taylor D; Das M; Sharma T Neuropsychopharmacology; 2003 Dec; 28(12):2199-208. PubMed ID: 12942142 [TBL] [Abstract][Full Text] [Related]
18. The effects of nicotine on cognition are dependent on baseline performance. Niemegeers P; Dumont GJ; Quisenaerts C; Morrens M; Boonzaier J; Fransen E; de Bruijn ER; Hulstijn W; Sabbe BG Eur Neuropsychopharmacol; 2014 Jul; 24(7):1015-23. PubMed ID: 24766971 [TBL] [Abstract][Full Text] [Related]
19. Chronic nicotine improves cognitive performance in a test of attention but does not attenuate cognitive disruption induced by repeated phencyclidine administration. Amitai N; Markou A Psychopharmacology (Berl); 2009 Jan; 202(1-3):275-86. PubMed ID: 18618099 [TBL] [Abstract][Full Text] [Related]
20. Nicotine enhances but does not normalize visual sustained attention and the associated brain network in schizophrenia. Hong LE; Schroeder M; Ross TJ; Buchholz B; Salmeron BJ; Wonodi I; Thaker GK; Stein EA Schizophr Bull; 2011 Mar; 37(2):416-25. PubMed ID: 19713300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]